Louise O'Keefe

Dr. Louise O'Keefe


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in Experimental Neurology
Verified
Journal Article
Closed access
DWDani L. Webber
Dani L. Webber
ACAmanda Choo
Amanda Choo
LHLaura J. Hewson
Laura J. Hewson
PTPaul J. Trim
Paul J. Trim
MSMarten F. Snel
Marten F. Snel
LOLouise O'Keefe
Louise O'Keefe

29 June 2021 in Cells
Verified
Journal Article
Open access
PDF file
CLCheng Shoou Lee
Cheng Shoou Lee
ACAmanda Choo
Amanda Choo
SDSonia Dayan
Sonia Dayan
RRRobert I. Richards
Robert I. Richards
LOLouise O'Keefe
Louise O'Keefe
It is now more than 20 years since the FRA16D common chromosomal fragile site was characterised and the WWOX gene spanning this site was identified. In this time, much information has been discovered about its contribution to disease; however, the normal biological role of WWOX is not yet clear. Experiments leading to the identification of the WWOX gene are recounted, revealing enigmatic relationships between the fragile site, its gene and the encoded protein. We also highlight research mainly using the genetically tractable model organism Drosophila melanogaster that has shed light on the integral role of WWOX in metabolism. In addition to this role, there are some particularly outstanding questions that remain regarding WWOX, its gene and its chromosomal location. This review, therefore, also aims to highlight two unanswered questions. Firstly, what is the biological relationship between the WWOX gene and the FRA16D common chromosomal fragile site that is located within one of its very large introns? Secondly, what is the actual substrate and product of the WWOX enzyme activity? It is likely that understanding the normal role of WWOX and its relationship to chromosomal fragility are necessary in order to understand how the perturbation of these normal roles results in disease.